| David R Worth, DPM | |
|
752 N High Point Rd, Madison, WI 53717-2236 | |
| (608) 824-4000 | |
| (608) 824-4910 |
| Full Name | David R Worth |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 31 Years |
| Location | 752 N High Point Rd, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568427482 | NPI | - | NPPES |
| 1568427482 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 736-025 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Health Systems Inc | 7012827983 | 1068 |
News Archive
Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness - but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain.
Saussurea controversa is a perennial herbaceous plant that has been traditionally used by the people of the Far East, Siberia, Tibet, and Mongolia to treat liver, kidney, digestive tract, and locomotive diseases. Its dried leaves are sold in pharmacies because their decoction is widely used as a medicine against cold and bronchitis. To understand what substances this plant owes its medicinal properties to, a team of scientists from Siberian State Medical University and Tomsk Polytechnic University extracted individual components from the plant and determined their composition.
Nearly 20% of hospitalizations by Medicare beneficiaries are followed by readmission within 30 days, costing billions of dollars in healthcare costs. Existing approaches to identify patients at risk for hospitalization are limited to episodic claims data. These claims-based approaches often fail to detect avoidable and costly admissions in the blind spot between doctor visits.
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.
› Verified 2 days ago
| Provider Name | Dean Health Systems Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053358846 PECOS PAC ID: 7012827983 Enrollment ID: O20031105000584 |
News Archive
Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness - but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain.
Saussurea controversa is a perennial herbaceous plant that has been traditionally used by the people of the Far East, Siberia, Tibet, and Mongolia to treat liver, kidney, digestive tract, and locomotive diseases. Its dried leaves are sold in pharmacies because their decoction is widely used as a medicine against cold and bronchitis. To understand what substances this plant owes its medicinal properties to, a team of scientists from Siberian State Medical University and Tomsk Polytechnic University extracted individual components from the plant and determined their composition.
Nearly 20% of hospitalizations by Medicare beneficiaries are followed by readmission within 30 days, costing billions of dollars in healthcare costs. Existing approaches to identify patients at risk for hospitalization are limited to episodic claims data. These claims-based approaches often fail to detect avoidable and costly admissions in the blind spot between doctor visits.
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David R Worth, DPM 752 N High Point Rd, Madison, WI 53717-2236 Ph: (608) 824-4000 | David R Worth, DPM 752 N High Point Rd, Madison, WI 53717-2236 Ph: (608) 824-4000 |
News Archive
Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness - but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain.
Saussurea controversa is a perennial herbaceous plant that has been traditionally used by the people of the Far East, Siberia, Tibet, and Mongolia to treat liver, kidney, digestive tract, and locomotive diseases. Its dried leaves are sold in pharmacies because their decoction is widely used as a medicine against cold and bronchitis. To understand what substances this plant owes its medicinal properties to, a team of scientists from Siberian State Medical University and Tomsk Polytechnic University extracted individual components from the plant and determined their composition.
Nearly 20% of hospitalizations by Medicare beneficiaries are followed by readmission within 30 days, costing billions of dollars in healthcare costs. Existing approaches to identify patients at risk for hospitalization are limited to episodic claims data. These claims-based approaches often fail to detect avoidable and costly admissions in the blind spot between doctor visits.
Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.
An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma, according to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center.
› Verified 2 days ago
Ruben Silva, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 888-478-8321 | |
Steven J. Merckx, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6661 Odana Road, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Associated Podiatrists, Llp Podiatrist Medicare: Medicare Enrolled Practice Location: 6661 Odana Rd, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Neal Jay Katz, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 664 W Washington Ave, Madison, WI 53703 Phone: 608-241-0848 Fax: 608-767-2015 | |
Nealan Marshall Prather, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Overlook Ter, Madison, WI 53705 Phone: 608-256-1901 | |
Stephen C Bogue, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6661 Odana Road, Madison, WI 53719 Phone: 608-829-2535 Fax: 608-829-1319 | |
Dr. Robyn Winner Paloian, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 451 Junction Rd, Madison, WI 53717 Phone: 608-263-8915 Fax: 608-265-5755 |